Observational Study
Copyright ©The Author(s) 2023.
World J Hepatol. Jun 27, 2023; 15(6): 813-825
Published online Jun 27, 2023. doi: 10.4254/wjh.v15.i6.813
Table 5 Association of alanine aminotransferase level, all-cause, cardiovascular disease, cancer-related and others-related mortality among nonalcoholic fatty liver disease patients in women
Mortality outcome, ALT levelNo. of death, n (%)Unadjusted
Age-adjusted
Multivariate-adjusted
HR (95%CI)
P value
HR (95%CI)
P value
HR (95%CI)
P value
All-cause
< 0.5 ULN144 (34.0)111
0.5-1 ULN440 (38.8)1.16 (0.96-1.40)0.1270.88 (0.73-1.06)0.1760.91 (0.74-1.10)0.348
1-2 ULN187 (36.0)1.05 (0.85-1.31)0.6320.83 (0.67-1.03)0.0950.76 (0.60-0.97)0.027
≥ 2 ULN46 (30.7)0.89 (0.64-1.24)0.4841.10 (0.79-1.53)0.5850.82 (0.52-1.31)0.416
Cardiovascular disease
< 0.5 ULN41 (9.7)111
0.5-1 ULN119 (10.5)1.10 (0.77-1.58)0.5940.82 (0.58-1.17)0.2820.86 (0.59-1.26)0.44
1-2 ULN442 (8.1)0.83 (0.54-1.28)0.410.65 (0.42-1.00)0.0510.62 (0.38-1.02)0.061
≥ 2 ULN99 (6.0)0.61 (0.30-1.26)0.1820.78 (0.38-1.61)0.5040.85 (0.29-2.43)0.756
Cancer
< 0.5 ULN31 (7.3)111
0.5-1 ULN97 (8.6)1.18 (0.79-1.77)0.4250.93 (0.62-1.40)0.7281.02 (0.66-1.57)934
1-2 ULN37 (7.1)0.96 (0.60-1.55)0.8770.76 (0.47-1.23)0.2610.83 (0.49-1.44)0.482
≥ 2 ULN15 (10.0)1.34 (0.72-2.48)0.3521.38 (0.74-2.57)0.3091.49 (0.61-3.68)0.395
Others
< 0.5 ULN71 (49.7)111
0.5-1 ULN224 (50.9)0.91 (0.70-1.20)0.5260.92 (0.71-1.20)0.5490.89 (0.67-1.18)0.411
1-2 ULN108 (57.8)1.01 (0.75-1.37)0.9351.08 (0.80-1.46)0.6270.85 (0.61-1.20)0.366
≥ 2 ULN22 (47.8)0.99 (0.62-1.61)0.9781.16 (0.72-1.88)0.5480.62 (0.30-1.29)0.199